Sammanfattning
Salvage radiotherapy (SRT) for biochemical recurrence (BCR) following radical prostatectomy (RP) should if possible be added at a prostate-specific antigen (PSA) level of <1-2 ng/mL. The value of positron emission tomography combined with computed tomography (PET/CT) at such low PSA values is not defined. The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases.
Originalspråk | engelska |
---|---|
Sidor (från-till) | 1749-1752 |
Tidskrift | World Journal of Urology |
Volym | 33 |
Nummer | 11 |
DOI | |
Status | Published - 2015 |
Ämnesklassifikation (UKÄ)
- Urologi och njurmedicin